RGC Resources RGCO Weighted-average grant date fair value of stock options (in dollars per share)

Weighted-average grant date fair value of stock options (in dollars per share) at other companies

FMC CorporationFMC

$9.14-29.9%

KemperKMPR

$21.44+14.0%

QuidelOrtho CorporationQDEL

$17.83-26.8%

RepligenRGEN

$65.80-18.2%

Utah Medical ProductsUTMD

$16.74-15.3%

Achieve Life SciencesACHV

$3.81+13.7%

Other financials

Income statement

See full

Revenue$45.5M+24.7%

Operating income$4.6M+8.0%

Net income$8.7M+163%

EPS (diluted)$0.32+11.2%

Balance sheet

See full

Cash & equivalents$3.4M+57.6%

Total debt$147.1M+27.3%

Total equity$124.1M+5.3%

Total assets$337.1M+3.3%

Cash flow

See full

Operating cash flow$15.4M-26.7%

CapEx$4.2M-15.7%

Free cash flow$11.2M-30.1%

Valuation

See full

Market cap$248.73M+8.8%

Enterprise value$392.45M+7.1%

P/E12.3×-5.4×

P/S2.3×-0.1×

Profitability

See full

Gross margin50%—

Operating margin19.4%-0.8pp

Net margin18.9%+5.2pp

FCF margin9.4%+2.2pp

Returns & leverage

See full

Return on equity16.8%+5.8pp

Debt / equity1.2×+0.2×

Current ratio0.7×+0.1×

Where this comes from

Reported directly by RGC Resources in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue.

The official record: RGC Resources’s 10-K, filed December 4, 2025, on SEC EDGAR. View the filing →

Ask your AI about RGC Resources's weighted-average grant date fair value of stock options (in dollars per share).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is RGC Resources's weighted-average grant date fair value of stock options (in dollars per share)?: RGC Resources (RGCO) reported weighted-average grant date fair value of stock options (in dollars per share) of $0.00 in Q3 2025.
What does weighted-average grant date fair value of stock options (in dollars per share) mean?: This metric indicates the average fair value assigned to stock options at the time they are granted to employees. It is a critical measure for assessing the total cost of equity-based compensation and its dilutive potential for shareholders.